• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

JVI: Genetic requirement for hemagglutinin glycosylation and its implications for the influenza A H1N1 evolution

tetano

Editor, Senior Moderator
Published ahead of print 1 May 2013, doi: 10.1128/​JVI.00373-13 JVI.00373-13



Genetic requirement for hemagglutinin glycosylation and its implications for the influenza A H1N1 evolution

Jin Il Kima,b,
Ilseob Leea,b,
Sehee Parka,b,
Min-Woong Hwanga,b,
Joon-Yong Baea,b,
Sangmoo Leea,b,
Jun Heoa,b,
Mee Sook Parka,b,
Adolfo Garc?a-Sastrec,d,e and
Man-Seong Parka,b#

+ Author Affiliations

aDepartment of Microbiology
bCenter for Medical Science Research, College of Medicine, Hallym University, 1 Hallymdaehak-gil, Chuncheon, Gangwon-do 200-702, Korea
cDepartment of Microbiology
dDepartment of Medicine, Division of Infectious Diseases
eGlobal Health and Emerging Pathogens Institute, Mount Sinai School of Medicine, One Gustave L. Levy Place, Box 1124, New York, New York 10029, USA

ABSTRACT

Influenza A virus has evolved and thrived in human populations. Since the 1918 influenza A pandemic, human H1N1 viruses had acquired additional N-linked glycosylation (NLG) sites within the globular head region of hemagglutinin (HA) until the NLG-free HA head pattern of the 1918 H1N1 virus was renewed with the swine-derived 2009 pandemic H1N1 virus. Moreover, the HA of the 2009 H1N1 virus appeared to be antigenically related to that of the 1918 H1N1 virus. Hence it is possible that descendants of the 2009 H1N1 virus might recapitulate the acquisition of HA head glycoslylation sites through their evolutionary drift as a means to evade pre-existing immunity. Here we evaluate the evolution signature of glycosylations found in the globular head region of H1 HA in order to determine their impact in virulence and transmission of H1N1 viruses. We identified a polymorphism at HA residue 147 associated with the acquisition of glycosylation at residues 144 and 172. By in vitro and in vivo analyses using mutant viruses, we also found that the polymorphism at HA residue 147 compensated for the loss of replication, virulence and transmissibility associated with the presence of the N-linked glycans. Our findings suggest that the polymorphism in H1 HA at position 147 modulate viral fitness by buffering the constraints caused by N-linked glycans, and provide insights into the evolution dynamics of influenza viruses with implications in vaccine immunogenicity.


http://jvi.asm.org/content/early/2013/04/24/JVI.00373-13.abstract
 
Back
Top Bottom